According to a market report by Lucintel, the future of the global colorectal cancer diagnostic market looks promising with opportunities in the hospital, diagnostic center, cancer research center, and ambulatory surgical center markets. The global colorectal cancer diagnostic market is expected to reach an estimated $34 billion by 2030 from $22 billion in 2023, at a CAGR of 6.5% from 2023 to 2030. The major drivers for this market are increasing prevalence of cancer diseases, rising awareness and early diagnostic procedures, and increasing healthcare expenditure.
A more than 150-page
report is understand trends,
opportunity and forecast in colorectal cancer diagnostic market to 2030 by
product type (instruments and consumables & accessories), cancer type
(adenocarcinoma, colorectal lymphoma, gastrointestinal stromal tumors, and
carcinoid tumors), age group (geriatric, adults, and pediatric), end use
(hospitals, diagnostic centers, cancer research centers, and ambulatory
surgical centers), and region (North America, Europe, Asia Pacific, and the
Rest of the World).
Lucintel forecasts that instruments is expected to witness highest growth
over the forecast period due to the growing healthcare expenditure for cancer
diagnosis and increasing preference for preventive healthcare measures.
Within this market, diagnostic centers will remain the largest segment
due to growing need for cost effective diagnosis facilities for colorectal
cancer disease and rising number of diagnostic centers globally.
Download sample by clicking on colorectal
cancer diagnostic market.
North America is expected to witness highest growth over the forecast
period due to availability of advanced diagnostic procedure and techniques and
growing demand for colorectal cancer diagnostics testing.
General Electric, Siemens Healthcare, Koninklijke Philips, F. Hoffmann-La
Roche, Abbott, Illumina, Qiagen, Thermo Fisher Scientific, Quest Diagnostics,
Merck are the major suppliers in the colorectal cancer diagnostic market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1 972.636.5056
Explore Our Latest Publications
25-Hydroxy Vitamin D (25-OH-VD) ELISA Kit Market
No comments:
Post a Comment